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clinical benefits for percutaneous coronary
intervention with bare-metal stent implantation?
A meta-analysis of randomized controlled trials
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Carlos Faria Santos Amaral1,3 and Antonio L Ribeiro1,3Abstract
Background: The role of intravascular ultrasound (IVUS) in percutaneous coronary interventions (PCI) is still
controversial despite several previously published meta-analyses. A meta-analysis to evaluate the controversial role
of IVUS-guided PCI with bare-metal stenting was performed and a previous published meta-analysis was
re-evaluated in order to clarify the discrepancy between results of these studies.
Methods: A systematic review was performed by an electronic search of the PubMed, Embase and Web of
Knowledge databases and by a manual search of reference lists for randomized controlled trials published until
April 2011, with clinical outcomes and, at least, six months of clinical follow-up. A meta-analysis based on the
intention to treat was performed with the selected studies.
Results: Five studies and 1,754 patients were included. There were no differences in death (OR = 1.86; 95%
CI = 0.88-3.95; p = 0.10), non-fatal myocardial infarction (OR = 0.65; 95% CI = 0.27-1.58; p = 0.35) and major adverse
cardiac events (OR = 0.74; 95% CI = 0.49-1.13; p = 0.16). An analysis of the previous published meta-analysis strongly
suggested the presence of publication bias.
Conclusions: There is no evidence to recommend routine IVUS-guided PCI with bare-metal stent implantation.
This may be explained by the paucity and heterogeneity of the studies published so far.
Keywords: Intravascular ultrasound, Meta-analysis, Publication bias, Bare-metal stent, Percutaneous coronary
intervention, Coronary artery diseaseBackground
Since the first studies of intravascular ultrasound (IVUS)
were published in 1989 [1-4], the technique has been
widely used in clinical research and has contributed to
technological improvements in interventional cardiology
[5]. As a diagnostic tool, IVUS helps in the assessment
of coronary lesions classified as moderate based on angi-
ography, especially those located in the left main* Correspondence: lucaslodi@yahoo.com.br
1Instituto de Avaliação de Tecnologias em Saúde (IATS), do Hospital das
Clínicas da Universidade Federal de Minas Gerais (UFMG), Avenida Alfredo
Balena, 110, CEP, 30130-100, Belo Horizonte, MG, Brazil
2Setor de Hemodinâmica do Hospital das Clínicas da UFMG, Avenida Alfredo
Balena, 110, CEP, 30130-100, Belo Horizonte, MG, Brazil
Full list of author information is available at the end of the article
© 2012 Lodi-Junqueira et al.; licensee BioMed
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumcoronary artery [6,7], and in the assessment of long
lesions, small artery lesions, bifurcations and in-stent re-
stenosis [8,9]. As an ancillary technique in percutaneous
coronary intervention (PCI), IVUS is useful in the evalu-
ation of the target lesion and during stent implantation
[10]. In theory, its use should reduce the risk of major
adverse cardiovascular events (MACE) because of lower
restenosis and stent thrombosis rates.
The first published systematic review evaluated the
role of IVUS in PCI as well as its cost-effectiveness and
did not show any difference between IVUS and angio-
guided PCI [11]. A few years later, a meta-analysis did
not show any reduction in death or myocardial infarction
(MI) but revealed reductions in repeat revascularizationCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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[12]. This was corroborated by another meta-analysis that
suggested an improvement in acute post-interventional
results (larger minimal luminal diameter) and lower repeat
revascularization, angiographic restenosis and MACE rates,
but showed no effect on death or MI during the follow-up
period of six to thirty months [13].
Since IVUS clinical benefit is still controversial and
conclusions of meta-analyses may be misleading due to
methodological issues, we performed a meta-analysis to
assess the effect of IVUS in PCI with bare-metal stent
implantation on clinically relevant outcomes, assessing
the presence of publication bias. In addition, a critical
review of the last published meta-analysis [13] was per-
formed in order to clarify the discrepancy in the results
found in this analysis comparing to medical literature.
Methods
The protocol for the present systematic review was
based on the PRISMA Statement [14] and it was regis-
tered in the PROSPERO database (CRD42012002767).
Strategy search
We performed an electronic search of PubMed, Embase
and Web of Knowledge databases with the following
terms: Myocardial Ischemia; Ischemic Heart Disease;
Acute Coronary Syndrome; Angina; Coronary Disease;
Coronary Artery Disease; Coronary Occlusion; Coronary
Thrombosis and Myocardial Infarction, in association
with the terms Interventional Ultraso*; Intravascular
Ultraso*; Intracoronary Ultraso*; IVUS and ICUS.
A manual search was also performed to retrieve
potential articles cited in previous meta-analyses, in
review articles and those considered to be relevant by
the reviewers. The electronic search, which evaluated
the articles included in the databases through April
2011, was limited neither by publication date nor by
language.
Eligibility criteria
Only randomized controlled trials that compared IVUS-
guided PCI with angiography-guided PCI, with clinical
outcomes, and at least six months of clinical follow-up,
were included in quantitative synthesis. The clinical out-
comes considered were death, nonfatal MI and the com-
bined endpoint of MACE (death, nonfatal MI, or repeat
revascularization). For repeat revascularization, a report
of any new coronary revascularization (surgical or percu-
taneous) was considered, regardless of the lesion and of
the vessel treated. Surrogate outcomes, such as angio-
graphic outcomes, were not taken into account because
these can show a positive result with no effect (or harm-
ful effect) on clinical outcomes [15]. These clinicaloutcomes (death, nonfatal MI and MACE) were consid-
ered primary endpoints in our meta-analysis.
Study selection
The titles and abstracts from the articles retrieved by the
search strategy had been independently evaluated by two
reviewers (LCP, LLJ). All articles in which IVUS was
mentioned were selected. These articles were fully read,
and those that met the criteria were included. Disagree-
ments were solved by consensus. If consensus was not
achieved, a third reviewer (ALR) defined the question.
Statistical analysis
The intention-to-treat meta-analysis that followed the
systematic review was performed by the random-effects
model of the Comprehensive Meta-Analysis software
(Borenstein M, Hedges L, Higgins J, Rothstein H. Ver-
sion 2.2.048, Biostat, Englewood NJ, USA 2005), with
the odds ratio (OR), 95% confidence intervals and two-
sided P-values calculated for each outcome. The analysis
of heterogeneity between studies was estimated by the I2
statistic.
Publication bias evaluation was performed by Duval
and Tweedie’s Trim and Fill method [16]. Egger's test
was also performed to analyze the impact of several fac-
tors on the size of the treatment effect [17]. The small
study effect was also evaluated by cumulative analysis




A total of 4,247 articles in PubMed, 869 in Embase and
4,260 in Web of Knowledge databases were identified.
Eight studies were selected according to the inclusion
criteria (Figure 1) [18-26]. After a comprehensive ana-
lysis, three studies were excluded because they used a
provisional stenting technique [19,25,26], which is no
longer performed because of its higher restenosis rate
[27]. Table 1 summarizes the clinical and angiographic
characteristics of the patients included in the selected
studies.
Qualitative study analysis
There were significant differences between the five stud-
ies included in the final analysis (Table 2). One of the
current indications of IVUS-guided PCI is for patients
with long lesions (greater than 15 or 25 mm) [8,28,29],
who have been excluded from most studies [18,20,24].
Unlike the others, the TULIP study excluded those
patients who had focal lesions (less than 20 mm in
length). Every study but the AVID trial excluded patients
with a current or past history of acute coronary syn-





































Figure 1 Article selection flowchart. Flowchart based on the PRISMA Flow Diagram [14].
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caused a selection bias. In the AVID trial, the IVUS ana-
lysis was only performed after implantation of the stent,
excluding the initial assessment of the target lesion [8].
The criteria for optimal stent implantation were het-
erogeneous. Only the OPTICUS study used the criteria
proposed by the MUSIC study [10]. The majority of
patients underwent angiographic assessment after six
months (angiographic follow-up) [20,22,24]. Another
difference between the studies was in the criteria used
for MACE. In the RESIST study, MI was not included.
In the TULIP study, the MACE criteria included death,
nonfatal MI and ischemia-driven target lesion revascu-
larization (TLR). In the AVID trial, the composition of
this outcome was not explained. In the other studies,
the criteria for repeat revascularization were more
comprehensive and included coronary artery bypass
grafting (CABG) or a repeated PCI for any reason
[18,20,21,24].Heterogeneity
The heterogeneity among the studies showed intermedi-
ate values in nonfatal MI (I2= 48.82%) and MACE
(I2= 57.38%). For death, no heterogeneity was observed
among the studies (I2= 0%).
Publication bias
We also evaluated the possibility of publication bias
(B0) for MACE. Egger’s Test (B0 =−3.43; 95% CI− 6.40
to −0.47, one-tailed P-value 0.02) and the trim and fill
test (observed OR 0.74, 95% CI 0.49 to 1.13; two stud-
ies imputed: adjusted OR 0.93, 95% CI 0.60 to 1.44)
(Figure 2) were positive, suggesting the presence of small
studies effects, which can be attributable to differences in
design (not detected) or to publication bias.
Meta-analysis results
A total of 1,754 patients were randomized in five studies.
There was no statistically significant difference between
Table 1 Patient characteristics
Study DIPOL AVID RESIST TULIP OPTICUS
IVUS QCA IVUS QCA IVUS QCA IVUS QCA IVUS QCA
Demographic characteristics
Patients, n 83 80 369 375 79 76 73 71 273 275
Age. years, mean± SD 56± 8 54± 8 62± 12 63 ± 11 57 ± 10 56 ± 12 63 ± 10 61 ± 10 60.1 ± 10 61.5 ± 9.5
Men,% 71 73 73 68 86 93 71 72 77 78
Smoker,% 47 52 - - 55 51 40 43 0.69 0.66
Previous MI,% 44 40 35 29 54 48 - - 0.32 0.32
Previous CABG,% - - 18 20 - - - - 0.03 0.04
Previous PCI,% - - 24 25 - - - - 0.2 0.2
Diabetes mellitus.% 10 11 15 17 9 8 21 16 0.17 0.17
Dyslipidemia,% 47 40 40 44 54 52 62 61 0.61 0.67
Hypertension,% - - 46 45 24 26 30 27 0.48 0.52
LV ejection fraction,%, mean± SD 52± 9 48 ± 10 53 ± 13 55 ± 13 51 ± 9 53± 13 - - 56.5 ± 14 57.7 ± 14.3
Angiographic characteristics
Target vessel,%
- Left anterior descending artery 41 46 40 37 48 47 39 38 51 50
- Left circumflex artery 26 24 15 18 11 11 10 21 18 14
- Right coronary artery 33 30 35 32 41 42 51 41 30 35
- Left main coronary artery - - 0.8 0.5 - - - - - -
Lesion length, mm, mean± SD N/A N/A 13.0 ± 7.7 13.3 ± 9.2 7.7 ± 3.5 8.0 ± 4.0 27.0 ± 9 29.0 ± 10 11.9 ± 5.1 11.6 ± 5.5
Reference diameter, mm, mean± SD 3.21 ± 0.64 3.19 ± 0.59 3.05 ± 0.64 3.00 ± 0.54 3.0 ± 0.64* 2.89 ± 0.54* 2.95 ± 0.57 2.96 ± 0.53 2.97 ± 0.53 3.01 ± 0.51
Type B2 or C ACC/AHA lesions,% 13 10 N/A N/A 43 48 100 100 76 78
Pre-intervention
- Minimum lumen diameter, mm, mean± SD 0.97 ± 0.33 0.95 ± 0.32 1.11 ± 0.5 1.09 ± 0.47 0.96 ± 0.37 1.02 ± 0.44 1.02 ± 0.42 0.99 ± 0.41 0.96 ± 0.35 0.99 ± 0.34
- Diameter stenosis,%, mean± SD 69.7 ± 14.2 70.2 ± 11.4 63.4 ± 14.1 63.5 ± 14.3 65.0 ± 11.0 64.0 ± 12.0 65.0 ± 13.0 65.0 ± 10.0 67.6 ± 11.2 66.7 ± 10.1
Post-intervention
- Minimum lumen diameter, mm, mean± SD 3.34 ± 0.55 3.06 ± 0.52 2.93 ± 0.55 2.87 ± 0.48 2.48 ± 0.43 2.46 ± 0.46 3.01 ± 0.40 2.80 ± 0.31 3.02 ± 0.49 2.91 ± 0.41
- Diameter stenosis,%, mean± SD 3.4 ± 2.9 8.9 ± 5.4 N/A N/A 19.0 ± 10.0 19.0 ± 9.0 12.0 ± 7.0 13.0 ± 9.0 2.8 ± 7.8 6.0 ± 8.0
* In the RESIST study, the reference diameter average was calculated. MI, myocardial infarction; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; LV, left ventricular; ACA, American College



















Table 2 Study characteristics
Study DIPOL AVID RESIST TULIP OPTICUS
Enrolling years 2000 to 2002 1995 to 1998 1995 to 1997 1991 to 2001 1996 to 1998
Randomized Yes Yes Yes Yes Yes
- Blinded? Yes Yes N/A N/A Yes
- When? Pre-intervention Pre-intervention Post-intervention Pre-intervention Pre-intervention
Intention-to-treat analysis No Yes No Yes Yes
Exclusion criteria
- Long lesions Yes (> 25 mm) No Yes (> 15 mm) No Yes (> 25 mm)
- Bifurcation Yes No No Yes Yes
- Left main coronary artery Yes Yes No No Yes
- Chronic total occlusion Yes Yes Yes Yes No
- Recent acute coronary
syndrome
Yes No (except MI with
TIMI flow grade< 3)
Yes Yes Yes
- Small vessels Yes (≤ 2.75 mm) Yes (< 2.5 mm) Yes (< 3 mm) Yes (< 3 mm) Yes (< 2.5 mm)




Age< 18 y; non-covered
dissection; large vessels
(> 3.25 mm)
Previous CABG Focal (< 20 mm)
or ostial lesions
Pre-intervention IVUS Yes No No Yes Yes
Post-intervention IVUS Yes Yes Yes Yes Yes













Stenosis < 10% and
MUSIC study criteria [10]
- PCI success by IVUS,% 96 63 61 89 82.2 and
56 (MUSIC)
Clinical follow-up, months 6 12 18 12 12
Angiographic
follow-up, months
6* 6 (com USIC) 6 6
MACE Death, nonfatal MI,
repeat revascularization†






*Angiographic follow-up was left to the discretion of the operator: 87.9% (IVUS-guided group) and 83.7% (angio-guided group). †CABG or repeat PCI for any
reason. IVUS, interventional ultrasound; PCI, percutaneous coronary intervention; MACE, major adverse cardiovascular events; CSA, cross sectional area; MI,
myocardial infarction; TIMI, thrombolysis in myocardial infarction; CABG, coronary artery bypass graft; MLD, minimum lumen diameter; clinical TLR, ischemia-driven
target lesion revascularization.
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group (Table 3) for death (OR 1.86, 95% CI 0.88 to 3.95,
P= 0.10) (Figure 3-A), nonfatal MI (OR 0.65, 95%
CI 0.27 to 1.58, P= 0.35) (Figure 3-B) or MACE
(OR 0.74, 95% CI 0.49 to 1.13, P= 0.16) (Figure 3-C).Reviewing published data
In order to clarify the discrepancy in MACE results
found in this analysis compared to the medical literature,
the data of a previously published meta-analysis [13]
were re-evaluated (Figure 4). Among the studies selected
by that meta-analysis, only two were not included in the
present selection because the provisional stenting tech-
nique was employed in both of them [19,25].
A funnel plot analysis was performed along with
Egger’s Test (B0 =−3.66, 95% CI− 5.54 to −1.78, one-
tailed P-value = 0.002) and the trim and fill test(observed OR 0.70, 95% CI 0.50 to 0.98; three studies
imputed: adjusted OR 0.89, 95% CI 0.62 to 1.27), which
suggested the presence of publication bias [16,17].
A cumulative meta-analysis by reverse order of sample
size was performed. The results only became positive
when the last and smallest study was included in the
analysis (Figure 5). Moreover, the one-study-removed
analysis showed that the removal of any one of the smal-
ler studies gave a neutral result from the meta-analysis
(Figure 6). This makes it plausible to assume that one
small unpublished study with negative results would be
enough to nullify the effect of that meta-analysis.Discussion
In this rigorously conducted meta-analysis of rando-
mized controlled trials that compared IVUS-guided PCI
with angiography-guided PCI using bare metal stents,
Figure 2 Duval and Tweedie’s trim and fill test. The funnel plot shows the observed studies (white circles) and the imputed studies (black
circles) in addition to the observed (white diamond) and adjusted combined effect (black diamond).
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egy over the standard method in clinically relevant out-
comes. Indeed, we found evidence of publication bias
and of significant heterogeneity among the studies
regarding the outcomes MI and MACE. These results
diverge from the last two meta-analyses on this topic
[12,13], which included studies with provisional stenting,
considered surrogate outcomes, and did not evaluate the
presence of publication bias. However, they are in con-
cordance with recently published studies of IVUS-
guided PCI with drug-eluting stent implantation, which
were not associated with significant clinical benefits
[30,31].
Differences between selected studies
The five selected studies have important differences that
might lead to completely different outcomes in another
context. For example, the exclusion of patients present-
ing with ACS may have led to a reduction in post-
interventional adverse events [32-35]. In the AVID trial,
pre-interventional IVUS was not performed, which
excluded an important phase of the method because one
of the roles of IVUS is to assess the target lesion to helpTable 3 Clinical Outcomes
Study DIPOL AVID RESIST
IVUS QCA IVUS QCA IVUS Q
Patients, n 83 80 369 375 79
Death, n (%) 1 (1.2) 1 (1.3) 12 (3.3) 7 (1.9) 1 (1.3) 1
Nonfatal MI, n (%) 1 (1.2) 4 (5) 25 (6.8) 19 (5.1) N/A N
MACE, n (%) 6 (7.2) 13 (16.2) 68 (18.4) 70 (18.7) 20 (25.3) 28
*The analysis of nonfatal MI excludes the RESIST Study, where this outcome was no
events; IVUS, interventional ultrasound.in the choice of technique and devices for the PCI [8].
Only the OPTICUS study used the MUSIC study criteria
for optimal stent implantation [10], which theoretically
could be associated with a lower MACE rate [36].
Angiographic follow-up was performed in most studies,
which may have led to an overestimated rate of repeat
revascularization, due to the oculo-stenotic reflex [37],
which is the predisposition to indicate a PCI for any sig-
nificant luminal obstruction, despite the presence or ab-
sence of myocardial ischemia [38]. The fact that most
studies have used more comprehensive criteria for re-
peat revascularization may have also increased MACE
rates [18,20,24].
Study biases
The data analysis suggested the presence of publication
bias in both meta-analyses. This bias may have led to ap-
parently positive results that could be easily modified by
unpublished studies with small sample sizes. It may be
harmful because it can maintain or amplify an apparent
beneficial effect of the intervention [39].
Significance-chasing bias is an enticing term that refers
to the clustering of the most common types of meta-TULIP OPTICUS Total
CA IVUS QCA IVUS QCA IVUS QCA
76 73 71 273 275 877 877
(1.3) 2 (2.7) 1 (1.4) 5 (1.8) 1 (0.36) 21 (2.4) 11 (1.3)
/A 1 (1.4) 5 (7.0) 6 (2.2) 10 (3.6) 33 (4.1) 1 38 (4.7) 1
(36.8) 9 (12.3) 19 (26.8) 49 (17.9) 42 (15.3) 152 (17.3) 172 (19.6)
t calculated. MI, myocardial infarction; MACE, major adverse cardiovascular
A – Death    
B – MI 
C – MACE 
Figure 3 Meta-analysis by outcomes (random effects). (A) Death. (B) Myocardial infarction (MI). (C) Major adverse cardiovascular events
(MACE).
Figure 4 Original data from the re-evaluated meta-analysis - MACE [13].
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Figure 5 Cumulative meta-analysis. Each line includes the combined analysis of the corresponding study and the other ones above. The
studies were added from largest to smallest sample size.
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negative results remain unpublished (study publication
bias and selective outcome reporting bias), those in
which negative results become positive (selective analysis
reporting bias) and those in which no existing data are
presented as positive (fabrication bias) [40,41].
Selective reporting bias is the most common prob-
lem in meta-analyses. In selective outcome reporting
bias, specific data with a negative result are omitted
from publication. In selective analysis reporting bias,
which is even more frequent, a negative result calcu-
lated from a pre-determined analysis plan is replaced
by a positive result achieved through post hoc data
analysis [41].
Another major problem is the potential presence of
interests other than scientific truth. This matter becomes
critical when the object of the meta-analysis is an indus-
try product, as in the present study, because most of the
researches are conducted or funded by manufacturers
(Table 4) [42,43]. There is a current trend towards op-
posing this practice [44].
Meta-analyses have gained prestige over time but they
are still considered by some to be an ancillary method,Figure 6 One-study-removed method. Each line excludes the corresponaccepted only when it corroborates the point of view of
experts and of public policies [41]. They could play a
fundamental role in changing (or in supporting) the evi-
dence on relevant issues if conducted properly, with a
pre-specified analysis plan and declared conflicts of
interest for every study included, in addition to deter-
mining and reporting all possible biases.Limitations
The paucity of randomized controlled trials comparing
IVUS-guided PCI and angio-guided PCI and the exclu-
sion of groups with specific lesions (long lesions, small
vessels, bifurcations or left main coronary artery) may
have masked a possible benefit. The same point applies
to the exclusion of patients presenting with ACS,
whose rate of cardiovascular events is higher, and PCI,
when indicated, may even reduce mortality [32-34].
The low statistical power of the present study and of
the re-evaluated meta-analysis [13] is due to the pres-
ence of heterogeneity and to the possibility of study pub-
lication bias. The presence of other biases might be
possible but that is even more difficult to prove.ding study from the combined analysis.
Table 4 Study funding and conflicts of interest of the
authors of original articles included in this meta-analysis
Trial Industry funding Conflicts of interest (authors)
DIPOL None declared N/A
AVID None declared Accumetrics; Baxter; BDS; Boston
Scientific; Cardium; Conor Medical;
Cordis; Johnson & Johnson;
Medtronic; Volcano
RESIST None declared N/A
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The clinical benefit of IVUS-guided PCI with bare-metal
stent implantation could be determined neither by the
meta-analysis presented in this study nor by the re-
evaluated meta-analysis. This may be explained by the
paucity and heterogeneity of the studies published so far.
Furthermore, both meta-analyses showed possible publi-
cation biases.
Therefore, there is no evidence so far to recommend
routine IVUS-guided PCI with bare-metal stent implant-
ation. Studies on specific subgroups and performance of
a simple large randomized trial could show different
results.
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